On November 18, 2021 Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, reported it will host an investor presentation webcast on Thursday, December 2, 2021 at 2:00 p.m. ET (11:00 a.m. PT) (Press release, Nuvo Pharmaceuticals, NOV 18, 2021, View Source [SID1234595794]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

During the webcast, Jesse Ledger, President & Chief Executive Officer and Mary-Jane Burkett, Vice President & Chief Financial Officer of Miravo will provide a PowerPoint presentation that will cover key areas of Miravo’s business. During the presentation, investors will have an opportunity to ask questions through an interactive Q&A portal.

To access the webcast or to ask questions during the live event, please pre-register at the following link: View Source;tp_key=8127b0e5a0.

An archived version of the webcast and presentation will be available on the Presentations & Webcasts page of the Company’s website, View Source following the event.